Potential new therapeutic for Relapsing MS patients
Potential new therapeutic for Relapsing MS patients
RADIANCE phase 2 trial of ozanimod, an investigational selective S1P 1 and 5 receptor modulators for relapsing multiple sclerosis (MS) patients results showed significant reductions in the cumulative number of total gadolinium-enhancing (GdE) lesions...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1660 Views
-
Last post by Petr75
-
- 0 Replies
- 1300 Views
-
Last post by jimmylegs
-
- 2 Replies
- 1141 Views
-
Last post by David1949
-
- 0 Replies
- 2576 Views
-
Last post by NHE
-
- 0 Replies
- 1462 Views
-
Last post by frodo
-
- 0 Replies
- 1476 Views
-
Last post by NHE
-
- 0 Replies
- 2238 Views
-
Last post by frodo
-
- 5 Replies
- 13434 Views
-
Last post by gibbledygook